Targeting the Wolbachia Cell Division Protein FtsZ as a New Approach for Antifilarial Therapy by Li, Zhiru et al.
Targeting the Wolbachia Cell Division Protein FtsZ as a
New Approach for Antifilarial Therapy
Zhiru Li
1, Amanda L. Garner
2, Christian Gloeckner
2, Kim D. Janda
2, Clotilde K. Carlow
1*
1New England Biolabs, Division of Parasitology, Ipswich, Massachusetts, United States of America, 2Departments of Chemistry and Immunology and Microbial Science,
The Skaggs Institute for Chemical Biology, and The Worm Institute for Research and Medicine, The Scripps Research Institute, La Jolla, California, United States of America
Abstract
The use of antibiotics targeting the obligate bacterial endosymbiont Wolbachia of filarial parasites has been validated as an
approach for controlling filarial infection in animals and humans. Availability of genomic sequences for the Wolbachia (wBm)
present in the human filarial parasite Brugia malayi has enabled genome-wide searching for new potential drug targets. In
the present study, we investigated the cell division machinery of wBm and determined that it possesses the essential cell
division gene ftsZ which was expressed in all developmental stages of B. malayi examined. FtsZ is a GTPase thereby making
the protein an attractive Wolbachia drug target. We described the molecular characterization and catalytic properties of
Wolbachia FtsZ. We also demonstrated that the GTPase activity was inhibited by the natural product, berberine, and small
molecule inhibitors identified from a high-throughput screen. Furthermore, berberine was also effective in reducing motility
and reproduction in B. malayi parasites in vitro. Our results should facilitate the discovery of selective inhibitors of FtsZ as a
novel anti-symbiotic approach for controlling filarial infection.
Note: The nucleotide sequences reported in this paper are available in GenBank
TM Data Bank under the accession number
wAlB-FtsZ (JN616286).
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Introduction
Filarial nematode parasites are responsible for a number of
devastating diseases in humans and animals. These include
lymphatic filariasis and onchocerciasis that afflict 150 million
people in the tropics and threaten the health of over one billion.
Unlike other nematodes, the majority of filarial species are infected
with an intracellular bacterium, Wolbachia [1]. In the human filarial
nematode Brugia malayi, these obligate a-proteobacterial endosym-
bionts have been detected in all developmental stages [2–4].
Moreover, their presence is essential for the worm, as tetracycline-
mediated clearance of bacteria from Brugia spp. leads to develop-
mental arrest in immature stages and reduction in adult worm
fertility and viability [5–10]. These findings have pioneered the
approach of using antibiotics to treat and control filarial infections.
However, in humans, tetracycline therapy is not ideally suited for
widespread use because several weeks of treatment are required and
the drug has contra-indications for certain individuals. Therefore,
there is considerable interest in identifying new endosymbiont drug
targets and other classes of compounds with anti-Wolbachia activity.
Importantly, the completed genome sequence of the Wolbachia
endosymbiont of B. malayi (wBm) [11] now enables genome-wide
mining for new drug targets [11–14] and a foundation for rational
drug design. These approaches should lead to the discovery of new
classes of compounds with potent anti-Wolbachia/antifilarial activ-
ities targeting essential processes that are absent or substantially
different in the mammalian host.
Bacterial cytokinesis has emerged as a major target for the
design of novel antibacterial drugs [15–17] since several of the
components that are essential for multiplication and viability are
absent from mammals. The bacteria-specific ‘‘filamenting tem-
perature sensitive’’ protein, FtsZ, plays a central role during
bacterial cytokinesis. In Escherichia coli, temperature sensitive
mutations in the ftsZ gene cause blockage in cell division with
limited cell growth and the generation of long filaments. FtsZ
assembles into the contractile Z-ring and coordinates more than a
dozen other cell division proteins at the midcell site of the closing
septum [18–21]. Formation of the septal Z-ring requires two
important functional properties of FtsZ, namely, polymerization of
the FtsZ monomers into protofilaments and GTPase activity.
Since inhibition of either function is lethal to bacteria, both GTP-
dependent polymerization [22–27] and enzymatic [27–28]
activities of FtsZ have been targeted for the identification of new
antibacterial agents. Several inhibitors have been discovered
including synthetic compounds [17,29] and natural products
[17,30–33].
In the present study, we identify the cell division machinery
present in wBm and characterize the FtsZ protein (wBm-FtsZ).
Using quantitative real time RT-PCR, Wolbachia ftsZ was found to
be expressed throughout the life cycle, but up-regulated in fourth
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shown to possess a robust GTPase activity, which was inhibited by
the natural plant product berberine. Berberine was also effective in
reducing motility and reproduction in B. malayi parasites in vitro.A
library of small molecules was also examined for its inhibitory
activity against the wBm and E. coli FtsZ proteins. Several
compounds were identified as potent inhibitors, and structure-
activity relationship studies revealed a derivative with selectivity
for wBm-FtsZ. Thus, our results support the development of wBm-
FtsZ as a promising new drug target in an anti-symbiotic approach
for controlling filarial infection.
Materials and Methods
Cloning of ftsZ from the Wolbachia endosymbiont of the
human filarial parasite B. malayi (wBm-ftsZ)
Living B. malayi adult female worms were purchased from TRS
Laboratories, Athens GA. Genomic DNA and RNA were isolated
following the protocols developed by Dr. Steven A. Williams
(http://www.filariasiscenter.org/molecular-resources/protocols).
To clone full-length wBm-ftsZ for expression studies, forward
59(GAGAGCTAGCATGTCAATTGACCTTAGTTTGCCAG)39
(NheI site underlined) and reverse 59(GAGACTCGAGTTACTT-
CTTTCTTCTTAAATAAGCTGG) 39 (XhoI site underlined)
primers were designed according to the wBm-ftsZ sequence (accession
number: YP_198432) in order to amplify the gene from B. malayi
genomic DNA. The PCR product was then cloned into the NheI and
XhoIsitesofpET28a(+) (Novagen) to generate a fusion protein with a
His6 tag at the N terminus. The authenticity of the insert was verified
by sequencing.
Wolbachia ftsZ gene expression in various developmental
stages of B. malayi
Total RNA supplied by the Filariasis Research Resource Center
(FR3) was treated with RNase-free Dnase (New England Biolabs,
Cat# M0303S) and purified using the RNeasy Kit from Qiagen.
cDNA was obtained using random primers and the ProtoScriptH
AMV First Strand cDNASynthesis Kit (New England Biolabs,Cat#
E6550S). Forward primer 59 (AACAAGAGAGGCAAGAGCTG-
GAGT) and reverse primer 59(CGCACACCTTCAAAGCCAAA-
TGGT) were utilized to amplify a 102 bp Wolbachia ftsZ amplicon.
Wolbachia 16S rRNA amplified with forward primer 59 (TGA-
GATGTTGGGTTAAGTCCCGCA) and reverse primer 59(AT-
TGTAGCACGTGTGTAGCCCACT) was utilized for bacterial
total RNAquantification. B.malayi18S rRNA amplified with forward
primer 59 (ACTGGAGGAATCAGCGTGCTGTAA) and reverse
primer 59(TGTGTACAAAGGGCAGGGACGTAA) was utilized
as a total worm RNA control. Quantitative PCR was performed
using the DyNAmo
TM HS SYBRH Green qPCR Kit (Thermo
Fisher)anda CFX-96 RealTimePCRinstrument (Bio-rad,Hercules,
CA). Relativelevelsof ftsZ expression (ratio of ftsZ to 16S rRNA), and
abundance of Wolbachia in B.malayi(ratio of Wolbachia16S to B.malayi
18S rRNA) were calculated for each RNA sample. Experiments were
performed twice with triplicate samples. Controls consisting of
samples processed in the absence of reverse transcriptase were
included in qPCR and no DNA contamination was detected.
Identification and cloning of FtsZ from the Wolbachia
endosymbiont of Aedes albopictus
To determine the sequence of the ftsZ gene from the Wolbachia
endosymbiont wAlB present in the insect cell line Aa23 [34],
multilocus sequence typing (MLST) ftsZ forward 59 (TGTA-
AAACGACGGCCAGTATYATGGARCATATAAARGATAG)
and reverse 59 (CAGGAAACAGCTATGACCTCRAGYAATG-
GATTRGATAT) [35] primers were utilized to obtain a PCR
fragment. Using BLAST analysis, the sequence of the PCR
product was compared to the corresponding region of known full-
length ftsZ sequences and their conserved downstream and
upstream sequences and 6 additional primers 59(TCTATTTT-
TAATTCTTTTAGAGAAGCATT), 59(CGTTCGGTTTTGA-
AGGTGTGC), 59 (ACCGTTGTGGGAGTGGGTGGT), 59 (T-
TATTTTTTTCTTCTTAAATAAGCTGGTATATC), 59 (GG-
AATGACAATAAGTGTATCTACGTA), and 59(TGCATTTG-
CAGTTGCTCATCC) were designed to obtain a complete wAa-
ftsZ sequence. PhusionH High-Fidelity DNA Polymerase (New
England Biolabs, M0530) was utilized for all PCR reactions
according to manufacturer’s instructions.
Expression and purification of recombinant Wolbachia
FtsZ proteins
wBm-ftsZ and E. coli ftsZ (Ec-ftsZ) were amplified using genomic
DNA isolated from B. malayi and E. coli wild-type strain MG1655
respectively, and were then cloned into the pET28a plasmid to
generate fusion proteins with a N-terminal His tag. Each protein
was expressed in the Escherichia coli strain C2566 (New England
Biolabs). Optimum conditions for production of soluble recombi-
nant wBm-FtsZ involved co-transformation with the pRIL plasmid
isolated from BL21-CodonPlus (DE3) cells (Stratagene) together
with the pET28a-ftsZ plasmid. Cultures were grown at 37uC till the
OD600 reached 0.6, before induction with 0.1 mM IPTG overnight
at 16uC. Both Ec-FtsZ and wBm-FtsZ were purified using a similar
method. The cells expressing the recombinant proteins were
suspended in lysis buffer (20 mM NaPO4, 500 mM NaCl,
10 mM imidazole, pH 7.4) plus 1 mg/mL lysozyme and protease
inhibitor cocktail (Roche)and incubated on ice for 30 min, followed
by sonication. The lysate was then cleared by centrifugation at
12,500 rpm, 4 uC for 30 min. The His-tagged proteins were
purified on a 5 mL HiTrap chelating HP column (GE Healthcare)
using an AKTA FPLC following manufacturer’s instructions. After
application of the sample, the column was washed with 5 column
volumes of buffer A (20 mM NaPO4, 500 mM NaCl, 10 mM
imidazole, pH 7.4) followed by 10 column volumes of 92% buffer
Author Summary
Filarial nematode parasites are responsible for a number of
devastating diseases in humans and animals. These include
lymphaticfilariasisand onchocerciasis thatafflict 150million
people in the tropics and threaten the health of over one
billion. The parasites possess intracellular bacteria, Wolba-
chia, which are needed for worm survival. Clearance of
these bacteria with certain antibiotics leads to parasite
death.Thesefindings havepioneeredthe approachofusing
antibiotics to treat and control filarial infections. In the
presentstudy,wehaveinvestigatedthecelldivisionprocess
in Wolbachia for new drug target discovery. We have
identified the essential cell divisionproteinFtsZ,whichhasa
GTPase activity, as an attractive Wolbachia drug target. We
describe the molecular characterization and catalytic
properties of the enzyme and demonstrate that the GTPase
activity is inhibited by the natural product, berberine, and
small molecule inhibitors identified from a high-throughput
screen. We also found that berberine was effective in
reducing motility and reproduction in B. malayi parasites in
vitro. Our results should facilitate the discovery of selective
inhibitors of FtsZ as a novel antibiotic approach for
controlling filarial infection.
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imidazole, pH 7.4). Protein was then eluted using a linear gradient
(8–100%) of buffer B equivalent to 40–400 mM imidazole.
Fractions containing wBm-FtsZ or Ec-FtsZ were pooled, dialyzed
against dialysis buffer (40 mM Tris-HCl, 200 mM NaCl and 50%
glycerol, pH 7.5) and stored at 220uC prior to use. Purity of the
proteins was estimated by 4–20% SDS-PAGE and the protein
concentration was determined using the Bradford assay.
GTPase enzyme assay
GTPase activity was measured using an enzyme-coupled assay
[36]. Activity was determined by measuring the consumption of
NADH, which is monitored by absorbance at 340 nm. The amount
of NADH oxidized to NAD corresponds to the amount of GDP
produced in the reaction. Reactions were optimized for a 96-well
formatto enable compound screening.The 100 mLreaction mixture
containing 50 mM MOPS (4-morpholinepropanesulfonic acid)
pH 6.5, 50 mM KCl, 5 mM MgCl2,1 mM PEP, 500 mM NADH,
0.1% Tween-20, 20 units/mL of L-lactate dehydrogenase (Sigma
L2518) and pyruvate kinase (Sigma P7768), 1 mM GTP and 5 mM
FtsZ was distributed into 96-well plates. The plate was incubated at
30 uC for 45 min with data collected at 20 second intervals using a
SpectraMaxH Plus 384 (Molecular Devices) spectrophotometer.
Control assays without FtsZ were performed to provide a baseline
and with GDP to ensure the function of the coupling enzymes.
For inhibitor screening, 100 mL of reaction mixture was added
to each well of a 96-well plate and 1 mL of compound dissolved in
DMSO, or berberine sulfate (MP Biomedicals) in water, in varying
concentrations were added. The reaction was initiated at 30 uCb y
adding 1 mM GTP. Experiments were performed in triplicate.
Effect of berberine on B. malayi
Living B. malayi adult female and male worms were washed
extensively with RPMI1640 medium supplemented with 2 mM
glutamine, 10% Fetal Calf Serum (Gibco) and 100 U/mL
streptomycin, 100 mg/mL penicillin, 0.25 mg/mL amphotericin B
(Sigma).Three worms of either gender were distributed into each well
of a 6-well plate and incubated at 37 uC, 5% CO2. After overnight
recovery,motilityandmicrofilaria productionwere recorded.Worms
were then transferred to a new well containing varying amounts of
berberine sulfate dissolved in water, namely 40 mM, 20 mM, 10 mM
and 5 mM. Control wells containing either no drug or 10 mM
doxycycline, were also included. Culture media were replaced with
fresh medium containing drug daily. Adult worm and microfilaria
motility production were recorded daily as described [37]. Motility
was scored as described [38] and expressed as % of motility relative to
motility scored on day 0 of the experiment. Microfilaria production
was counted in 10 mL of either diluted or concentrated culture
medium using a hemocytometer. The results were presented as the
number of microfilaria released in 1 mL of medium from each well
on the indicated day. Each treatment was performed in triplicate and
the experiment was repeated several times.
Effect of berberine on E. coli growth
Berberine sulfate (MP Biomedicals) was added at a final
concentration of 0–400 mM to growth medium containing E. coli
ER1613 (acrA13 D(top-cysB)204 gyrB225 IN(rmD-rmE) mcrA) (New
England Biolabs) and growth determined during 5 h or 20 h of
incubation. For the 5 h evaluation, an overnight culture of E. coli
ER1613 (acrA13 D(top-cysB)204 gyrB225 IN(rmD-rmE) mcrA) (New
England Biolabs) was diluted 100-fold and 1 mL volumes were
dispensed into a 48-well deep well plate (Axygen Scientific)
containing various concentrations (0–400 mM) of berberine sulfate
(10 mL of serial diluted berberine sulfate in water). The plate was
then incubated at 30 uC with shaking. After 90 min of initial
growth, bacterial growth was determined every 30 min for 5 h by
monitoring absorption at 600 nm using a microtiter plate reader
(Spectramax M5, Molecular Devices). Alternatively, an overnight
culture of E. coli was diluted 1:1000 fold and incubated with
varying amounts of berberine sulfate for 20 h before growth was
determined. All experiments were performed at least twice.
Viability of berberine sulfate-treated (24 h) cells was evaluated
by spotting 3 mL serial dilutions (10
22–10
27) of bacteria on a petri
dish and incubation overnight at 30 uC.
Bacterial morphology was visualized using a Zeiss AxioVert 200
microscope and images were obtained using a 206objective.
General chemistry methods for library synthesis
Reactions were carried out under a nitrogen atmosphere with
dry, freshly distilled solvents under anhydrous conditions, unless
otherwise noted. Yields refer to chromatographically and spectro-
scopically homogenous materials, unless otherwise stated. Reac-
tions were monitored by thin-layer chromatography (TLC) carried
out on 0.25-mm EMD silica gel plates (60F-254) using UV-light
(254 nm). Flash chromatography separations were performed on
Silicycle silica gel (40–63 mesh). Purity analyses were performed
using HPLC (254 nm).
General synthetic procedure for library compounds
A stirring solution of aldehyde (1.0 equiv) in MeOH at 25uC was
treated with carboxylic acid (2.0 equiv), amine (2.0 equiv) and
isonitrile (2.0 equiv). The solution was heated to reflux, and stirred
for 24 h. The solution was then cooled to 25uC and concentrated in
vacuo. The crude residue was purified via flash column chromatog-
raphy (10–50% EtOAc in hexanes) to afford the purified product.
For characterization data, see references [39–40].
Results
Genomic organization of the major cell division genes in
wBm
The bacterial cell-division pathway has been extensively studied
in E. coli and several essential proteins have been identified [17,19].
Many of the genes encoding putative orthologs of these proteins are
alsopresent in wBm (Table 1).A total of 18 major cell division genes
were identified in wBm genome (Table 1), including ftsZ, ftsA, ftsI,
ftsK, ftsQ and ftsW, which are known to be essential for cell division
[17]. These wBm genes were mapped and found to be more
scattered throughout the genome, in comparison with their E. coli
homologs. In E. coli the majority of genes were found in one major
operon, with the remaining 5 genes distributed randomly. Of these,
FtsZ was one of the most highly conserved essential proteins
possessing 43% identity to Ec-FtsZ (Table 1).Wolbachia ftsA, ftsI, ftsK,
ftsQ and ftsW were less related (13–34%) to the E. coli homologs.
Some previously described essential cell division genes in E. coli
(including ftsB, ftsL, ftsN and ZipA) were not found in wBm,
indicating that there are differences in the cell division machinery
present in free living E. coli and intracellular Wolbachia.
Sequence analysis of wBm-ftsZ
wBm-ftsZ exists as a single gene on the chromosome and is
1182 bp in length. It encodes a 394-amino acid protein with a
predicted molecular mass of 42 kDa containing four distinct
domains characteristic of FtsZ proteins. These comprise the variable
N-terminal domain, a highly conserved core region, variable spacer,
and a C-terminal conserved domain. The core region contains the
highly conserved catalytic aspartate residue [41–42] and the
GGGTGTGA motif (8 residues see [41,43]), which are responsible
Inhibition of Wolbachia FtsZ for Drug Discovery
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The C-terminal region is not required for assembly, but is essential
for interactions with the cell division proteins FtsA, FtsW and ZipA
[17]. A similar organization was also found in the insect Wolbachia,
wMel-FtsZ (NP_966481) and wAlB-FtsZ (JN616286). The FtsZ
proteins of Wolbachia from different hosts share 89–91% identity and
43%identitytoE.coliFtsZproteins,withasubstantiallylowerlevelat
the carboxyl-terminal region (17.2% identity).
Analysis of wBm-ftsZ expression during the life cycle of B.
malayi
Wolbachia have been identified in all developmental stages of B.
malayi, from studies on individual worms and isolates from regions
endemic for lymphatic filariasis [2–4]. To determine the relative
expression of wBm-FtsZ throughout the parasite life cycle and
validate its suitability as a drug target, wBm-ftsZ mRNA expression
was analyzed by quantitative real-time reverse transcription
polymerase chain reaction (qRT-PCR). Relative levels of ftsZ
expression (ratio of Wolbachia ftsZ to 16S rRNA) and abundance of
Wolbachia in B. malayi (ratio of Wolbachia 16S to B. malayi 18S
rRNA) were calculated for each RNA sample.
wBm-ftsZ was found to be expressed throughout all stages
examined (adult female and male worms, microfilariae, third- and
fourth-stage larvae). Moreover, wBm-ftsZ/16S ratios were found to
be increased substantially following infection of the mammalian
host since levels were significantly higher (p value,0.001) in
fourth-stage larvae and adult female worms compared to the
vector-derived infective third-stage larvae. The wBm-ftsZ/16S
ratio was also higher in microfilariae compared with the vector-
derived third-stage larvae, but was significantly lower than the
ratios obtained for fourth-stage and adult female worms. Of the
various developmental stages examined, the lowest level of wBm-
ftsZ expression was found in male worms (Figure 1A). No DNA
contamination was detected in controls consisting of samples
processed in the absence of reverse transcriptase. Wolbachia 16S
rRNA/B. malayi 18S rRNA ratios were also determined to
measure the relative abundance of bacteria in different stages of
B. malayi (Figure 1B). Wolbachia was found to be most abundant in
fourth stage larvae and adult female worms and least abundant in
infective third stage larvae, indicating a massive multiplication of
Wolbachia soon after infection of the mammalian host. Taken
together, these data indicate that while wBm-ftsZ is expressed in all
stages, gene activity and bacterial multiplication is most pro-
nounced in fourth-stage larvae and adult females.
Expression and purification of recombinant wBm-FtsZ
Recombinant wBm-FtsZ was expressed in E. coli with a His-tag at
the C-terminus and purified by nickel-affinity chromatography
(Figure 2A). Optimum conditions for production of soluble
recombinant wBm-FtsZ involved growth of cultures at 37uCu n t i l
the OD600 reached 0.6, followed by induction with 0.1 mM IPTG
overnight at 16uC. Purified protein was eluted with 100 mM
imidazole. The apparent molecular weight of 43 kDa (Figure 2A)
was consistent with the predicted molecular size of wBm-FtsZ with
anN-terminalHis-tag.For comparativestudies, E. coli FtsZ (41 kDa)
was also expressed and purified in a similar manner (Figure 2B).
Recombinant wBm-FtsZ has GTPase activity
GTPase activity was measured using an enzyme-coupled
assay involving pyruvate kinase and lactate dehydrogenase [36].
GTP hydrolysis was determined by measuring the decrease in
fluorescence emission following oxidation of nicotinamide
adenine dinucleotide (NADH) to NAD (Figure 3A). As Figure 3B
shows, recombinant wBm-FtsZ was found to possess GTPase
activity. Moreover, the specific activities for wBm-FtsZ and















ftsW b0089 414 wbm0015 373 integral membrane protein involved in stabilizing FstZ ring during cell division 24.4
zapA b2910 109 wbm0057 105 protein that localizes to the cytokinetic ring 18.1
ftsI b0084 588 wbm0075 521 transpeptidase in septal peptidoglycan synthesis (penicillin-binding protein 3) 18.6
mraW b0082 313 wbm0107 333 16S rRNA m(4)C1402 methyltranserfase, SAM-dependent 34.2
ftsA b0094 420 wbm0113 412 ATP-binding cell division protein involved in recruitment of FtsK to Z ring 23.3
murC b0091 491 wbm0118 556 UDP-N-acetylmuramate:L-alanine ligase 27.7
mreB b3251 347 wbm0154 358 cell wall structural complex MreBCD, actin-like component MreB 53.0
murF b0086 452 wbm0238 455 UDP-N-acetylmuramoyl-tripeptide:D-alanyl-D-alanine ligase 27.9
ftsH b3178 644 wbm0490 609 protease, ATP-dependent zinc-metallo 46.5
murE b0085 495 wbm0492 496 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:meso-diaminopimelate ligase 25.2
murD b0088 438 wbm0508 498 UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase 22.8
murG b0090 355 wbm0557 343 N-acetylglucosaminyl transferase 22.4
ddl b0092 306 wbm0570 339 D-alanine:D-alanine ligase 29.4
ftsQ b0093 276 wbm0571 252 Divisome assembly protein, membrane anchored protein at septum 13.1
ftsZ b0095 383 wbm0602 396 GTP-binding tubulin-like cell division protein 42.8
mraY b0087 360 wbm0643 326 phospho-N-acetylmuramoyl-pentapeptide transferase 33.1
ftsK b0890 1329 wbm0644 707 DNA translocase at septal ring sorting daughter chromsomes 33.7
murB b3972 342 wbm0778 295 UDP-N-acetylenolpyruvoylglucosamine reductase, FAD-binding 19.3
*Only major E. coli cell-division proteins are shown.
doi:10.1371/journal.pntd.0001411.t001
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alkaloid berberine
Berberine, an alkaloid natural product, is a known inhibitor of
the GTPase activity of FtsZ in E. coli [33,44]. Thus, we were
interested in examining the generality of berberine’s GTPase
inhibitory activity against wBm-FtsZ. As Figure 4 shows, dose-
dependent inhibition (25–1000 mM) was found with an IC50 value
of 320 mM. E. coli FtsZ [33,44] was included for comparison, and
an IC50 value of 240 mM was observed (Figure 4). Since wBm-FtsZ
possesses all but one of the key residues proposed in the binding of
E. coli FtsZ to berberine (lysine instead of glycine at position 183 of
Ec-FtsZ), this may account for the higher concentration of
berberine required to inhibit 50% of wBm-Ftsz’s GTPase activity.
The effect of berberine on the motility and microfilariae
production of B. malayi in vitro
Since filarial Wolbachia remain unculturable, we were unable to
evaluate the direct effect of berberine on the endosymbiont.
Therefore, we examined the indirect effect of the drug on adult
female worm. As Figure 5A shows, berberine (10–40 mM) had
adverse effects on the motility of adult female B. malayi worms, as
well as microfilariae production (Figure 5B) when compared to
untreated controls. Two days after treatment with berberine
(40 mM), female worms showed almost no movement and the
production of microfilaria had virtually ceased. Berberine at
20 mM was comparable to 10 mM of doxycycline in terms of effect
on female worm motility. Reduction in adult female motility
coincided with a decrease in microfilariae production. Similarly,
motility of the freshly released microfilaria was decreased when
berberine was present, with some effect observed at the lowest
concentration (5 mM) tested (Figure 5C). On the other hand, male
worms were more resistant to the effects of the drug with limited
reduction in motility observed following treatment with berberine
(5–40 mM) for 6 days (Figure 5D). However, treatment with
100 mM berberine for 24 h did completely paralyze male worms
(data not shown). Doxycycline (10 mM) had a comparable affect on
the motility of male and female worms.
The effect of berberine on E. coli growth, morphology
and viability
To demonstrate that berberine’s in vitro GTPase inhibitory
activity and anti-parasitic activity correlates with its known
Figure 1. Wolbachia ftsZ gene expression in various developmental stages of B. malayi. Female adultworm,male adultworm,microfilaria,L3
and L4 were analyzed. The ratio of ftsZ to 16S rRNA (A) represents ftsZ gene expression, while the ratio of Wolbachia 16S to B. malayi 18S rRNA (B)
represents the relative abundance of Wolbachia in B. malayi. The data obtained from triplicate samples are expressed as a mean 6 standard deviation.
doi:10.1371/journal.pntd.0001411.g001
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ER1613. Berberine is known to act as a substrate for the multi-
drug resistance efflux pumps and ER1613 contains a mutation in
the acrA gene, which inactivates the multidrug efflux pump [45].
Overnight incubation of ER1613 with 0–100 mM berberine
showed a dose-dependent effect with complete inhibition of
bacterial growth observed at 60 mM (Figure 6A). Similarly, no
growth was evident when experiments were initiated with greater
bacterial densities and the cells were treated with 50 mM berberine
for up to 5 h (Figure 6B). Treatment with berberine resulted in the
filamentous phenotype (Figure 5C) typically observed in ftsZ
mutant strains [46], indicating that berberine was inhibiting cell
division. Moreover, the presence of elongated bacteria also
correlated with decreased growth and viability. Viability was also
evaluated by ability to form colonies on an agar plate. Berberine
sulfate-treated (24 hours) cells produced substantially fewer
colonies (Figure 6D), compared to untreated controls. Untreated
bacteria had approximately 4610
5 - fold growth in 24 h, whereas
bacteria treated with 40 mM berberine had 4610
2 - fold growth.
At concentrations of 80 mM and higher, the treated bacteria failed
to produce viable colonies (Figure 6D), demonstrating that without
active replication E. coli die.
Identification of new inhibitors of wBm-FtsZ GTPase
activity
To initiate a campaign to identify molecularly unique inhibitors
of wBm-FtsZ GTPase activity, a library of small molecules based
on naphthalene, quinoline and biphenyl core scaffolds were
examined [39–40] (Figure 7A). The library was constructed using
Ugi multicomponent reaction chemistry, and each compound
consists of a flat aromatic scaffold for enhanced p-stacking
interactions decorated with varying diversity elements (R
1–R
4 in
Figure 7A). Importantly, these scaffold motifs are also found in
berberine (Figure 7B) and known FtsZ inhibitors [17,29–33]. The
,500-member library was screened using the wBm-FtsZ GTPase
assay, and 13 compounds with greater than 30% inhibition at
100 mM were identified. From these screening efforts, compounds
AV-C6 and N938 (Figure 7C) emerged as leading hits, and each
showed dose-dependent inhibition of wBm-FtsZ (Figure 8A). AV-
C6 and N938 were also examined for inhibition of the E. coli FtsZ
enzyme (Figure 8A). As shown in Figure 8A, both compounds
inhibited Ec-FtsZ activity although each was slightly less potent
compared to the inhibitory activity against wBm-FtsZ.
Structure-activity relationship (SAR) studies were then per-
formed on N938 as this compound showed the most potential in
dose response experiments. In addition to identifying compounds
with enhanced potency, we were also interested in exploring the
possibility of tuning down any inhibitory activity against Ec-FtsZ in
order to obtain a more specific Wolbachia FtsZ inhibitor. A series of
analogues were synthesized with varying aromatic side chains (R
3
in Figure 7A). As shown in Figure 8B, both goals were met: N982
with an ortho-chloro substituent (Figure 7D) showed enhanced
potency in the wBm-FtsZ assay and N983 with a para-cyano
substituent (Figure 7D) showed some specificity for wBm-FtsZ over
that from E. coli. Future SAR studies should enable the discovery
of compounds with both enhanced inhibitory properties and
specificity. Finally, as the solubility of these compounds is poor,
100% inhibition of FtsZ with this scaffold was not possible and
true IC50 values could not be obtained. Scaffold modification and/
or hopping strategies will be investigated in the future to afford
enhanced solubility.
Discussion
The use of antibiotics targeting the Wolbachia endosymbionts of
filarial parasites has been validated as an approach for controlling
filarial infection in animals and humans. As a result, there is
considerable interest in identifying new compounds that specifi-
cally target the obligate bacterial endosymbiont. In the present
study, we investigated the cell division pathway in wBm to identify
Figure 2. Expression and purification of recombinant FtsZ proteins. FtsZ protein from Wolbachia (A) and E. coli (B) were expressed in E. coli
with a His-tag at the N-terminus and purified by nickel-affinity chromatography. The apparent molecular weight (indicated) from SDS–PAGE was
consistent with the predicted molecular size. Protein marker (M), total protein lysate (T), insoluble proteins (In), soluble (S) and purified FtsZ proteins
(P) are shown.
doi:10.1371/journal.pntd.0001411.g002
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new antifilarial therapies. Filamenting temperature sensitive (fts)
genes produce many of the proteins essential for cell division in E.
coli [17]. In wBm, we identified the majority of core genes that are
indispensable to cytokinesis including ftsA, ftsI, ftsK, ftsQ, ftsW and
ftsZ.
Interestingly, ftsB, ftsL, ftsN and ZipA were not found in wBm.
ZipA is a bitopic membrane protein with a large cytoplasmic
domain that binds and bundles FtsZ protofilaments in vitro and
helps to stabilize the Z ring in vivo. FtsN is a core component of the
divisome that accumulates at the septal ring at the initiation of the
constriction process. The C-terminal SPOR domain specifically
recognizes a transient form of septal murein, which helps trigger
and sustain the constriction process. However, in E. coli, it has
been found that alterations in FtsA can compensate for the
absence of ZipA, FtsK [47] and FtsN [48] and a gain-of-function
FtsA variant, FtsA*(R286W), efficiently stimulates cell division in
the complete absence of ZipA [47]. Thus, Wolbachia FtsA may
function like the mutant FtsA, as an alanine residue is present in
the same position.
ftsB, ftsL, ftsN and ZipA are also absent in some important
bacterial pathogens including certain Gram-negative (Neisseria spp.,
Bordetella pertussis, Helicobacter pylori, Chlamydia spp.) and Gram-
positive (Mycobacterium tuberculosis) bacteria and cell wall-lacking
(Mycoplasma pneumoniae) organisms [17]. It is likely that this reflects
the reduced genome size present in these intracellular bacteria.
FtsZ is the most highly conserved essential bacterial cell division
protein and is present in all bacteria except Chlamydia spp [17]. We
determined that wBm-FtsZ shares substantial similarity (43%
identity) to the highly characterized E. coli FtsZ protein and is
highly similar (,90% identity) to insect Wolbachia FtsZ proteins.
While the majority of wBm genes are expressed in a stage-specific
manner [49], wBm-ftsZ was found to be expressed in both male
and female worms as well as in all larval stages examined. It was
not surprising to find wBm-ftsZ expressed throughout the entire
lifecycle of the parasite since the bacterial Z-ring is known to exist
in a state of dynamic equilibrium in order to fulfill its many roles in
the cell. Using fluorescence recovery after photo bleaching
(FRAP), the E. coli Z-ring was found to continually remodel itself
with a halftime of 30 seconds with only 30% of cellular FtsZ
Figure 3. GTPase activity of recombinant wBm-FtsZ. Panel A,
activity was determined indirectly by measuring a decrease in NADH
concentration by its absorbance at 340 nm. FtsZ hydrolyzes GTP into
GDP and inorganic phosphate. The GDP product is used as a substrate
by pyruvate kinase (PK) in the presence of phosphoenol pyruvate (PEP)
to yield GTP and pyruvic acid as products. Pyruvic acid is used as a
substrate in the presence of NADH by lactate dehydrogenase (LDH) to
generate lactate and NAD. The consumption of NADH is proportional to
GTPase activity. Panel B, comparison of the GTPase activity of wBm-FtsZ
and Ec-FtsZ. A control without enzyme was also included. Activity was
indicated by a decrease of NADH measured by absorbance at 340 nm.
doi:10.1371/journal.pntd.0001411.g003
Figure 4. Berberine sulfate inhibition of the GTPase activity. Enzyme activity of wBm-FtsZ (N) and Ec-FtsZ (%) was determined in the
presence of 0, 25, 50, 100, 200, 400, 600, 800, and 1000 mM berberine sulfate. The data obtained from triplicate samples are expressed as a mean 6
standard deviation.
doi:10.1371/journal.pntd.0001411.g004
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within a cytoplasmic pool [17]. E. coli ftsZ transcription analysis
has revealed that the rate of ftsZ expression is constant with a
sudden doubling at a specific cell age, suggesting that ftsZ
expression is regulated [50]. Similarly, we observed up-regulation
of wBm-ftsZ gene expression in fourth-stage larvae and adult
female worms with microfilariae likely contributing to the
increased expression in the latter case. While the lowest levels of
gene expression were evident in adult males, FtsZ protein was
easily detected in proteomic analyses of male worms [49]. In
general, the gene expression pattern of ftsZ correlated with
bacterial multiplication. The increased bacterial multiplication in
the worm during early infection of the mammalian host and
embryogenesis is in agreement with an earlier study [4]. These
data are consistent with the third- and fourth-stage larval stages,
and embryogenesis being particularly sensitive to the effects of
Figure 5. Effect of berberine sulfate on B. malayi parasites in culture. Motility of adult female (A) and male (D) worms, and microfilariae (C)
was examined following 6 days exposure to varying amounts (5–40 mM) of berberine sulfate. 10 mM doxycycline was included as a control. Motility
was scored as described [38] and expressed as % of motility relative to motility scored on day 0 of the experiment. Micofilariae production (B) was
determined at each time point by counting the number of microfilaria present in 1 mL spent culture media. The data obtained from triplicate
samples are expressed as a mean 6 standard deviation.
doi:10.1371/journal.pntd.0001411.g005
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expression could be used as a marker to monitor Wolbachia
multiplication in the filarial parasite much like the ftsZ gene in the
intracellular bacterium Candidatus Glomeribacter gigasporarum that
resides in the mycorrhizal fungus Gigaspora margarita [43].
Molecular studies have established the importance of con-
served amino acids in the FtsZ protein that when changed results
in ftsZ mutants blocked at different stages of cell division
[42,46,52–55]. wBm-FtsZ possesses the key residues and
conserved GTP-binding pocket required for GTPase activity.
Our functional analysis revealed that the GTPase activities of
recombinant wBm-FtsZ and Ec-FtsZ are similar, and both
proteins are sensitive to the plant alkaloid berberine. Most of
the residues in Ec-FtsZ that are thought to bind berberine and
inhibit FtsZ GTPase activity are also present in wBm-FtsZ. An
earlier detailed study in E. coli determined that the target of this
commonly used compound is FtsZ [33]. Plants containing
berberine have been used in traditional Chinese and Native
American medicine to treat many infectious diseases and the
sulfate, hydrochloride and chloride forms are used in Western
pharmaceutical medicine as antibacterial agents [56]. It is active
against a number of Gram-positive and Gram-negative patho-
genic bacteria, including drug resistant Mycobacterium tuberculosis
[57] and Staphylococcus aureus [58].
Figure 6. Berberine sulfate inhibition of E. coli growth. Panel A, overnight growth of E. coli was determined in the presence of various
concentrations of berberine sulfate. Percentage of growth is indicated as 1006(OD600 nm with berberine/OD600 nm without berberine). The data
obtained from triplicate samples are expressed as a mean 6 standard deviation. Panel B, log-phase (5 h) growth (OD600 nm) of E. coli was determined
in the presence of various concentrations (10–70 mM) of berberine sulphate. Panel C, DIC micrographs of E. coli untreated (0 mM) or treated with
40 mMo r8 0mM berberine sulfate. Panel D, effect of berberine sulfate on E. coli viability. Viability of berberine sulfate-treated (24 hours) cells was
evaluated by plating serial dilutions (10
22–10
27) of bacteria (Output shown in duplicate) on a petri dish and incubation overnight at 30 uC. The
number of bacteria present in the inoculum used in the experiment (Input) is also shown.
doi:10.1371/journal.pntd.0001411.g006
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bacteriostatic and bacteriocidal effects. Since filarial Wolbachia
remain unculturable, we were unable to evaluate the direct effect of
berberine on the endosymbiont. However, following berberine
treatment, we did observe reductions in adult female worm and
microfilariae motility and microfilariae production. On the other
hand, we did not see any effect on male worms, which had the
lowest level of wBm-ftsZ gene expression. We examined berberine-
and doxycycline-treatedwormsfor Wolbachiaload by qPCR analysis
and did not observe a significant difference between control and
treated parasites. A similar result was also found in a study
evaluating the effects of globomycin and doxycycline on filarial
Wolbachia, and the authors [59] suggested several possibilities which
can also apply to our study, namely: the Wolbachia qPCR assay may
not have sufficient sensitivity to detect effects on Wolbachia load over
this time frame in nematodes, inhibition of FtsZ is sufficient to affect
nematode motility and viability independent of or prior to any effect
on Wolbachia load, and/or a direct effect of berberine on nematode
motility and viability and alternative mechanisms of action.
Nonetheless, our results suggest that FtsZ inhibitors that operate
via inhibition of enzyme activity including natural products [28,30–
33,53] and synthetic molecules [29,60] may have also activity
against wBm-FtsZ.
To complement the berberine studies, a library of naphthalene-,
quinoline- and biphenyl-based compounds constructed using
Ugi multicomponent reaction chemistry was examined for the
discovery of new and ultimately highly specific antagonists of
either E. coli or Wolbachia FtsZ. Of interest, compounds based on
similar scaffolds have already been demonstrated as potent FtsZ
inhibitors [17,29–33]. From our screening efforts, the (6-{butylcar-
bamoyl-[(aryl)-(butylcarbonyl)-amino]-methyl})-naphthen-2-ol scaf-
fold (Figure 7A, C) emerged as an antagonist of both E. coli and
Wolbachia FtsZ. Interestingly, from basic SAR studies it appears that
modification of the aryl substituent on the scaffold may afford
selectivity for Wolbachia FtsZ, a key element of our initial goal.
Additional compounds are currently being prepared to examine this
possibility. Although not discussed here, compounds based on our
lead scaffold had no effect on growth or viability in E. coli.B a s e do n
these findings and their potency in the in vitro assays, it is plausible
that penetrability or metabolism issues are to blame for their
attenuated activity. Finally, the solubility of these compounds is also
poor precluding measurement of true IC50 values. Further iterations
Figure 7. Structures of FtsZ inhibitors and scaffolds. General scaffolds for small molecule library compounds (A). Structure of berberine (B).
FtsZ inhibitors identified from the initial high-throughput screen (C). FtsZ inhibitors identified from SAR studies (D).
doi:10.1371/journal.pntd.0001411.g007
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liabilities.
While we have focused on assaying the GTPase activity of wBm-
FtsZ using a medium- to high-throughput coupled enzyme assay
for the discovery of inhibitors that target cell division in Wolbachia,
it is also possible to screen for compounds that would target wBm-
FtsZ via other mechanisms of action. FtsZ is considered a distant
functional relative of the mammalian cytoskeletal protein b-
tubulin [61–63]. Microtubule formation is a major target in cancer
chemotherapy and the anticancer drug Taxol binds to b-tubulin
and blocks cell division by interfering with microtubule formation.
Interestingly, the FtsZ inhibitor PC190723 [60] operates by a
similar mechanism and more recently, novel inhibitors of B. subtilis
cell division have been identified in an in vitro FtsZ protofilaments
polymerization assay [64]. Importantly, significant differences exist
in the active sites in tubulin and FtsZ polymers, and several small
molecule inhibitors of FtsZ have been identified [65] that do not
inhibit tubulin [66–67]. Tubulin is also the target of the broadly
anti-parasitic benzimidazole drugs [68–69], which have been used
extensively to control soil-transmitted nematodes [70–71].
FtsZ is also responsible for recruiting and coordinating more
than a dozen other cell division proteins at the midcell site of the
closing septum [18–19,21,72]. Many of these interactions are
essential and it has been suggested that they might also be useful
targets, particularly in light of developments in the discovery of
small molecule inhibitors of protein-protein interactions [17,73–
Figure 8. Inhibition of GTPase activity by small molecules. wBm-FtsZ (& andN) and Ec-FtsZ (% and #) were compared. Panel A, compounds
were tested at the concentration of 30, 40, 50, 60, 70, 80, 90, and 100 mM and the experiment were performed in duplicate, the mean value was
plotted. Panel B, compounds were tested at the concentration of 10, 20, 40, 60, 80, and 100 mM and the experiments were performed in triplicate, the
mean 6 standard deviation was plotted.
doi:10.1371/journal.pntd.0001411.g008
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interactions between wBm-FtsZ and its various binding partners
that modulate its polymerization. Another Wolbachia cell division
protein worth considering for drug discovery is FtsA, as this
protein also possesses enzymatic activity and contains an ATP-
binding site that might be targeted with drug-like molecules.
Moreover, this protein is essential in E. coli [75] and Streptococcus
pneumoniae [76].
In summary, we have investigated the cell division pathway in
wBm and determined that it possesses a FtsZ protein with GTPase
activity. We demonstrated that the activity is inhibited by
berberine and identified small molecule inhibitors in a high-
throughput screen. Furthermore, berberine was found to have
adverse affects on B. malayi adult worm and microfilariae motility,
and reproduction. Our results support the discovery of selective
inhibitors of Wolbachia FtsZ as a new therapeutic approach for
filariasis.
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